Further evidence that FeNO directed therapy reduces asthma exacerbations

J. Syk, J. Donohue, K. Alving, N. Herje, G. Crater (Stockholm, Solna, Sweden; Chapel Hill, Morrisville, United States Of America)

Source: International Congress 2014 – Airway biomarkers
Session: Airway biomarkers
Session type: Thematic Poster Session
Number: 1000
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Syk, J. Donohue, K. Alving, N. Herje, G. Crater (Stockholm, Solna, Sweden; Chapel Hill, Morrisville, United States Of America). Further evidence that FeNO directed therapy reduces asthma exacerbations. Eur Respir J 2014; 44: Suppl. 58, 1000

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


Exhaled nitric oxide and the therapeutic regimens in childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Different patterns of exhaled NO response to acute bronchodilation in asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Normal values of exhaled nitric oxide at 50 mL/s – A revisit
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013


The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Prevalence and relationship of hypomagnesiemia with children bronchial asthma control
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016

Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Non-invasive markers of airway eosinophilic inflammation in pre-school children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016